Seelos Therapeutics Inc (SEELQ)

[eicoman]

it's a good question, not likely, as APRI stated, in Canada they were trying to extend shelf life within the limits of changing the formula that Health Canada allows without having to completely re-apply for a new drug approval, or they were maybe trying to get Health Canada to agree to the formula in Europe, either way APRI now says, and Abbott says, they will be selling in 2014, so I would think they must have made some progress by now, and it should be sooner than later at this point, it's been 2 years since they partnered it, a ridiculously long time to launch.